PharmiWeb.com - Global Pharma News & Resources
16-Mar-2020

New CEO at curasan AG

curasan AG / Key word(s): Personnel
New CEO at curasan AG

16-March-2020 / 15:22 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


New CEO at curasan AG

Kleinostheim, March 16, 2020 - The supervisory board of curasan AG (DE000A2YPGM4), for which on February 23, 2020 an application for the opening of insolvency proceedings due to overindebtedness of the company with the responsible local court at Aschaffenburg has been filed, today has resolved to appoint Dr. jur. Alexander Baratta with immediate effect as the new CEO of the company.

Concurrently the supervisory board has resolved to dismiss Torben Sorensen with immediate effect from his office as CEO.

 

---- End of the ad hoc release ----


Contact curasan AG:
Andrea Weidner
Investor Relations &
Corporate Communications
+49 6027 40 900-51
ir@curasan.com


16-March-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: curasan AG
Lindigstra├če 4
63801 Kleinostheim
Germany
Phone: 06027/40 900 0
Fax: 06027/40 900 29
E-mail: info@curasan.de
Internet: www.curasan.de
ISIN: DE000A2YPGM4
WKN: A2YPGM
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 998211

 
End of Announcement DGAP News Service

Editor Details

Last Updated: 16-Mar-2020